Healthcare & Pharma

In phase 1 clinical trials, Tykerb proved so beneficial to participants that the FDA put the drug on the fast track for approval. Without phase II and III data, we had to find a way to tell oncologists and patients with late stage HER 2+ metastatic breast cancer why Tykerb would make their last year of life better, longer, and worth another medication. And we had to tell them, without telling them.

Consumer & B2B

Be better than the first—be the best. Be outlandish in city limits and innovative in freedom. Be colorful in black and white. Be homemade, handmade and played for generations to come. Be distinguished—even on the top shelf. Be found in translation, utterly irresistible, and never be left behind.

Digital & Broadcast

Roche Pharma Research and Early Development (pRED) invented a unique technology that allows for significantly more efficient penetration of biological therapeutics through the Blood-Brain-Barrier into the brain. This animation was created to introduce The Roche Brain Shuttle and the paradigm shift it is creating in the treatment and management of neurological disorders.